| David Hargrove Parker, MD | |
|
4 Physicians Park, Frankfort, KY 40601-4181 | |
| (502) 223-8400 | |
| (502) 875-3073 |
| Full Name | David Hargrove Parker |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 4 Physicians Park, Frankfort, Kentucky |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679571517 | NPI | - | NPPES |
| 201076390 | Medicaid | IN | |
| 64159163 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | 15916 (Kentucky) | Primary |
| Entity Name | Community Medical Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588614994 PECOS PAC ID: 7012811284 Enrollment ID: O20031120000656 |
News Archive
The worldwide impact of the COVID-19 pandemic led to an unprecedented effort to develop vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on a timescale that has never been imagined before. Even as some vaccines have begun to be administered on a large scale, scientists and governments are coming up against a difficult obstacle.
In the wake of a growing sexual harassment scandal that has been roiling UNAIDS and civil society, AIDS Healthcare Foundation (AHF), the largest AIDS organization that provides and supports HIV care to more than 889,000 patients in 39 countries globally, including Africa, Asia, Eastern Europe, Latin America & the Caribbean and the United States, is calling on the United Nations to outsource and appoint an independent third-party to investigate the case, which many believe was grossly mishandled by UNAIDS Executive Director Michel Sidibé and his superiors at the UN.
Adaptimmune Therapeutics plc, a clinical stage biopharmaceutical company focused on the use of T-cell therapy to treat cancer, today announced that the first patient has been dosed in its expanded Phase I/II trial of its affinity enhanced T-cell receptor therapeutic targeting the NY-ESO-1 cancer antigen in synovial sarcoma patients.
Humans use their whole bodies, not just their ears, to understand speech, according to University of British Columbia linguistics research.
When a baby's life was threatened by a rare pediatric cancer that would not respond to surgery or chemotherapy, doctors at Nemours Children's Hospital rapidly, successfully shrank the tumor by 90 percent using an experimental treatment, according to a new study published online in Pediatric Blood and Cancer.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David Hargrove Parker, MD Po Box 766351, Chicago, IL 60677-6351 Ph: (502) 588-9490 | David Hargrove Parker, MD 4 Physicians Park, Frankfort, KY 40601-4181 Ph: (502) 223-8400 |
News Archive
The worldwide impact of the COVID-19 pandemic led to an unprecedented effort to develop vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection on a timescale that has never been imagined before. Even as some vaccines have begun to be administered on a large scale, scientists and governments are coming up against a difficult obstacle.
In the wake of a growing sexual harassment scandal that has been roiling UNAIDS and civil society, AIDS Healthcare Foundation (AHF), the largest AIDS organization that provides and supports HIV care to more than 889,000 patients in 39 countries globally, including Africa, Asia, Eastern Europe, Latin America & the Caribbean and the United States, is calling on the United Nations to outsource and appoint an independent third-party to investigate the case, which many believe was grossly mishandled by UNAIDS Executive Director Michel Sidibé and his superiors at the UN.
Adaptimmune Therapeutics plc, a clinical stage biopharmaceutical company focused on the use of T-cell therapy to treat cancer, today announced that the first patient has been dosed in its expanded Phase I/II trial of its affinity enhanced T-cell receptor therapeutic targeting the NY-ESO-1 cancer antigen in synovial sarcoma patients.
Humans use their whole bodies, not just their ears, to understand speech, according to University of British Columbia linguistics research.
When a baby's life was threatened by a rare pediatric cancer that would not respond to surgery or chemotherapy, doctors at Nemours Children's Hospital rapidly, successfully shrank the tumor by 90 percent using an experimental treatment, according to a new study published online in Pediatric Blood and Cancer.
› Verified 5 days ago
Vernon Mitchell May, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 4 Physicians Park, Frankfort, KY 40601 Phone: 502-223-8400 Fax: 502-875-3073 | |
Suresh Saxena, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 4 Physicians Park, Frankfort, KY 40601 Phone: 502-223-8400 Fax: 502-875-3073 | |
Taunya M Jasper, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 4 Physicians Park, Frankfort, KY 40601 Phone: 502-223-8400 Fax: 502-875-3073 | |
Jennifer Ann Spath, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4 Physicians Park, Frankfort, KY 40601 Phone: 502-223-8400 Fax: 502-875-3073 | |
Bradley Coleman Chase, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 4 Physicians Park, Frankfort, KY 40601 Phone: 502-223-8400 Fax: 502-875-3073 | |
Janice Marie Kregor, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 4 Physicians Park, Frankfort, KY 40601 Phone: 502-223-8400 Fax: 502-875-3073 |